Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Apr-24 9:40 PM View:  | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 4,130,850 | -- | -- | 275% 1.5M to 5.63M | |
| 10-Apr-24 9:43 PM View: | Kalayoglu Murat Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 2,926,760 | -- | -- | 475% 616.5K to 3.54M | |
| 10-Apr-24 9:40 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 24,785 | -- | -- | (< 1%) 6.34M to 6.31M | |
| 10-Apr-24 9:40 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 826,169 | -- | -- | 15% 5.63M to 6.46M | |
| 10-Apr-24 9:47 PM View: | Singer Michael Director | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 110,151 | -- | -- | 529% 20.84K to 130.99K | |
| 10-Apr-24 9:43 PM View: | Kalayoglu Murat Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 491,853 | -- | -- | 395% 124.65K to 616.5K | |
| 10-Apr-24 9:40 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 123,925 | -- | -- | (2%) 6.46M to 6.34M | |
| 10-Apr-24 4:20 PM View: | Hoge Elizabeth 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Conversion | 3,418,620 | -- | -- | 2743% 124.64K to 3.54M | |
| 10-Apr-24 9:47 PM View: | Singer Michael Director | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 643,630 | -- | -- | 491% 130.99K to 774.62K | |
| 26-Mar-24 4:32 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 26-Mar-24 | Option Exercise | 1,970,440 | $1.46 | $2,876,850.00 | 5% 38.63M to 40.6M | |
| 20-Mar-24 5:09 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 18-Mar-24 | Private Purchase | 19,044 | $0.60 | $11,397.80 | < 1% 38.61M to 38.63M | |
| 28-Mar-24 5:11 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 18-Mar-24 | Purchase | 800 | $0.61 | $488.00 | < 1% 40.62M to 40.62M | |
| 28-Mar-24 5:11 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 15-Mar-24 | Purchase | 1,200 | $0.56 | $672.00 | < 1% 40.62M to 40.62M | |
| 18-Mar-24 5:29 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 15-Mar-24 | Purchase | 537,500 | $0.59 | $314,545.00 | 1% 38.07M to 38.61M | |
| 18-Mar-24 5:29 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 14-Mar-24 | Private Purchase | 648,372 | $0.54 | $351,677.00 | 2% 37.43M to 38.07M | |
| 28-Mar-24 5:11 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 14-Mar-24 | Purchase | 2,000 | $0.53 | $1,061.00 | < 1% 40.62M to 40.62M | |
| 28-Mar-24 5:11 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 13-Mar-24 | Purchase | 3,200 | $0.58 | $1,867.84 | < 1% 40.61M to 40.62M | |
| 28-Mar-24 5:11 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 12-Mar-24 | Purchase | 1,200 | $0.61 | $734.64 | < 1% 40.61M to 40.61M | |
| 28-Mar-24 5:11 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 11-Mar-24 | Purchase | 1,200 | $0.65 | $784.92 | < 1% 40.61M to 40.61M | |
| 28-Mar-24 5:11 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Mar-24 | Purchase | 4,800 | $0.66 | $3,186.72 | < 1% 40.61M to 40.61M | |
| 28-Mar-24 5:11 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 07-Feb-24 | Purchase | 2,400 | $0.66 | $1,575.12 | < 1% 40.6M to 40.61M | |
| 28-Mar-24 5:11 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 06-Feb-24 | Purchase | 800 | $0.65 | $520.00 | < 1% 40.6M to 40.6M | |
| 28-Mar-24 5:11 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 17-Jan-24 | Private Purchase | 800 | $0.69 | $552.00 | < 1% 40.6M to 40.6M | |
| 04-Jan-24 5:08 PM View: | Davis Blaine Chief Financial Officer | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 2,424,000 | -- | -- | 100% 0 to 2.42M | |
| 04-Jan-24 5:04 PM View: | Kalayoglu Murat Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 178,000 | -- | -- | 5% 3.56M to 3.74M | |
| 04-Jan-24 5:04 PM View: | Zenner Patrick J Director | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 178,000 | -- | -- | 322% 55.25K to 233.25K | |
| 04-Jan-24 5:03 PM View: | Kurtoglu Metin Chief Operating Officer | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 1,531,000 | -- | -- | 100% 0 to 1.53M | |
| 04-Jan-24 5:05 PM View: | Cox Carrie Smith Director | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 178,000 | -- | -- | 84% 212.88K to 390.88K | |
| 04-Jan-24 5:07 PM View: | Sallin Aymeric Director | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 178,000 | -- | -- | 100% 0 to 178.0K | |
| 04-Jan-24 5:06 PM View: | Miljkovic Milos Chief Medical Officer | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 548,200 | -- | -- | 100% 0 to 548.2K | |
| 04-Jan-24 5:06 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 178,000 | -- | -- | < 1% 37.25M to 37.43M | |
| 04-Jan-24 5:08 PM View: | Jewell Christopher M Chief Scientific Officer | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 778,200 | -- | -- | 100% 0 to 778.2K | |
| 04-Jan-24 5:06 PM View: | Barabe Timothy C Director | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 178,000 | -- | -- | 71% 250.01K to 428.01K | |
| 04-Jan-24 5:12 PM View: | Singer Michael Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 178,000 | -- | -- | 40% 447.39K to 625.39K | |
| 04-Jan-24 5:07 PM View: | Brunn Carsten President and CEO Director | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 4,654,100 | -- | -- | 1777% 261.96K to 4.92M | |
| 04-Jan-24 5:05 PM View: | Desilva Nishan M Director | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 178,000 | -- | -- | 2543% 7.0K to 185.0K | |
| 15-Nov-23 5:20 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-23 | Grant | 123,925 | $403.47 | $50,000,000.00 | < 1% 37.27M to 37.4M | |
| 15-Nov-23 5:20 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-23 | Grant | 24,785 | $403.47 | $10,000,000.00 | < 1% 37.25M to 37.27M | |
| 15-Nov-23 4:41 PM View: | Singer Michael Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 13-Nov-23 | Acquisition (other) | 337,271 | -- | -- | 306% 110.12K to 447.39K | |
| 15-Nov-23 5:26 PM View: | Brunn Carsten President and CEO Director | Cartesian Therapeutics, Inc. (RNAC) | 13-Nov-23 | Disposition | 521,125 | $2.06 | $1,073,520.00 | (67%) 783.08K to 261.96K | |
| 15-Nov-23 4:41 PM View: | Kalayoglu Murat Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 13-Nov-23 | Acquisition (other) | 3,303,700 | -- | -- | 1282% 257.74K to 3.56M | |
| 15-Nov-23 4:41 PM View: | Singer Michael Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 13-Nov-23 | Grant | 110,123 | -- | -- | 100% 0 to 110.12K | |
| 15-Nov-23 4:41 PM View: | Kalayoglu Murat Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 13-Nov-23 | Grant | 257,739 | -- | -- | 100% 0 to 257.74K | |
| 26-Sep-23 6:00 PM View: | Traber Peter G Chief Medical Officer | Cartesian Therapeutics, Inc. (RNAC) | 25-Sep-23 | Sale | 705 | $1.06 | $747.30 | (< 1%) 452.53K to 451.83K | |
| 26-Sep-23 6:01 PM View: | Brunn Carsten President and CEO Director | Cartesian Therapeutics, Inc. (RNAC) | 25-Sep-23 | Sale | 2,932 | $1.06 | $3,107.92 | (< 1%) 786.01K to 783.08K | |
| 01-Jun-23 4:27 PM View: | Kishimoto Takashi Kei Chief Scientific Officer | Cartesian Therapeutics, Inc. (RNAC) | 31-May-23 | Gift | 53,000 | -- | -- | (19%) 278.32K to 225.32K | |
| 01-Jun-23 4:27 PM View: | Kishimoto Takashi Kei Chief Scientific Officer | Cartesian Therapeutics, Inc. (RNAC) | 30-May-23 | Gift | 86,000 | -- | -- | (24%) 364.32K to 278.32K | |
| 06-Jan-23 5:15 PM View: | Kishimoto Takashi Kei Chief Scientific Officer | Cartesian Therapeutics, Inc. (RNAC) | 05-Jan-23 | Sale | 3,392 | $1.13 | $3,830.23 | (< 1%) 367.71K to 364.32K | |
| 06-Jan-23 5:16 PM View: | Brunn Carsten President and CEO Director | Cartesian Therapeutics, Inc. (RNAC) | 05-Jan-23 | Sale | 13,473 | $1.13 | $15,214.00 | (2%) 799.49K to 786.01K | |
| 06-Jan-23 5:15 PM View: | Traber Peter G Chief Medical Officer | Cartesian Therapeutics, Inc. (RNAC) | 05-Jan-23 | Sale | 3,465 | $1.13 | $3,912.67 | (< 1%) 449.59K to 446.12K |
